Cigna Corp
$ 268.63
-1.46%
15 Apr - close price
- Market Cap 72,818,500,000 USD
- Current Price $ 268.63
- High / Low $ 271.53 / 264.89
- Stock P/E 12.28
- Book Value 158.32
- EPS 22.19
- Next Earning Report 2026-04-30
- Dividend Per Share $6.04
- Dividend Yield 2.2 %
- Next Dividend Date -
- ROA 0.04 %
- ROE 0.15 %
- 52 Week High 342.75
- 52 Week Low 236.87
About
Cigna is an American multinational managed healthcare and insurance company based in Bloomfield, Connecticut. Its insurance subsidiaries are major providers of medical, dental, disability, life and accident insurance and related products and services, the majority of which are offered through employers and other groups (e.g. governmental and non-governmental organizations, unions and associations).
Analyst Target Price
$338.79
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-01-28 | 2025-10-30 | 2025-07-31 | 2025-05-02 | 2025-01-30 | 2024-10-31 | 2024-08-01 | 2024-05-02 | 2024-02-02 | 2023-11-02 | 2023-08-03 | 2023-05-05 |
| Reported EPS | 8.08 | 7.83 | 7.2 | 6.74 | 6.64 | 7.51 | 6.72 | 6.47 | 6.79 | 6.77 | 6.13 | 5.41 |
| Estimated EPS | 7.9 | 7.69 | 7.15 | 6.35 | 7.82 | 7.25 | 6.41 | 6.22 | 6.54 | 6.67 | 6.02 | 5.22 |
| Surprise | 0.18 | 0.14 | 0.05 | 0.39 | -1.18 | 0.26 | 0.31 | 0.25 | 0.25 | 0.1 | 0.11 | 0.19 |
| Surprise Percentage | 2.2785% | 1.8205% | 0.6993% | 6.1417% | -15.0895% | 3.5862% | 4.8362% | 4.0193% | 3.8226% | 1.4993% | 1.8272% | 3.6398% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-04-30 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 7.57 |
| Currency | USD |
Previous Dividend Records
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-03-19 | 2025-12-18 | 2025-09-18 | 2025-06-18 | 2025-03-20 | 2024-12-19 | 2024-09-19 | 2024-06-20 | 2024-03-21 | 2023-12-21 |
| Amount | $1.56 | $1.51 | $1.51 | $1.51 | $1.51 | $1.4 | $1.4 | $1.4 | $1.4 | $1.23 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: CI
2026-04-15 13:38:01
Baird has adjusted its price target for HCA Healthcare (HCA) to $442, down from $450, while reiterating a Neutral rating on the stock. This update reflects an analyst's revised valuation for the healthcare facilities operator. HCA Healthcare Inc. specializes in owning and operating various healthcare facilities, including hospitals, surgical centers, and endoscopy centers across the United States and the United Kingdom.
2026-04-15 12:47:00
Truist has lowered its price target for Medtronic (MDT) to $95 from $103, while maintaining a "Hold" rating on the stock. This adjustment reflects a revised outlook from the analyst firm on the medical equipment manufacturer. The article also mentions recent related news and other analyst adjustments for Medtronic.
2026-04-15 10:39:20
Ritholtz Wealth Management has acquired a new stake of 52,699 shares, valued at approximately $1.01 million, in Healthcare Services Group, Inc. (HCSG) during the fourth quarter. This move is part of a broader trend of institutional accumulation, with firms like 8 Knots Management and Ameriprise Financial significantly increasing their holdings. Healthcare Services Group recently exceeded Q4 EPS estimates, though analyst sentiment remains mixed with an average "Hold" rating.
2026-04-15 06:39:20
Healthcare Services Group (HCSG) is scheduled to release its Q1 2026 earnings before market open on Wednesday, April 22nd, with analysts forecasting $0.2371 EPS and $479.79 million in revenue. The company surpassed estimates in the previous quarter, reporting $0.44 EPS against a $0.23 consensus, and its stock currently holds a "Hold" rating from analysts with a consensus price target of $22.00. Recent insider selling totaled approximately 146,962 shares, valued at about $3.01 million, while institutional investors maintain a significant 97.97% ownership.
2026-04-14 20:06:59
AFLAC Inc. is highlighted as a strong investment due to its focus on supplemental health insurance, which addresses coverage gaps as U.S. healthcare costs rise. The company's diversified market presence in the U.S. and Japan, along with its consistent dividend history, makes it an attractive option for investors seeking stability and defensive growth. Analysts view AFLAC positively, citing its resilient business model and potential for shareholder returns despite regulatory and currency risks.
2026-04-14 15:09:44
CMS has selected over 150 healthcare organizations, including Verily and Noom, to participate in its new Advancing Chronic Care with Effective, Scalable Solutions (ACCESS) model. This voluntary 10-year program, starting July 5, 2026, aims to expand digital health technology access for chronic disease management through an outcomes-based payment option. Participants will receive recurring payments tied to patient outcomes for conditions like hypertension, diabetes, chronic musculoskeletal pain, and depression, with major payers also pledging support.
